Publications 2019

Meems LMG, Andersen IA, Pan S, Harty G, Chen Y, Zheng Y, Harders GE, Ichiki T, Heublein DM, Iyer SR, Sangaralingham SJ, McCormick DJ, Burnett JC (2019)
Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide
Hypertension, 73 (4), 900-909
DOI 10.1161/HYPERTENSIONAHA.118.12012, PubMed 30798663

Publications 2015

Andersen IA, Huntley BK, Sandberg SS, Heublein DM, Burnett JC (2015)
Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
Nephrol Dial Transplant, 31 (5), 767-72
DOI 10.1093/ndt/gfv398, PubMed 26666498

Publications 2012

Andersen IA, Igumnova E, Kildal AB, Myrmel T (2012)
Reassessment of a suggested pharmacological approach to heart failure: L-arginine is only a marginal NO donor in pigs
J Cardiovasc Pharmacol, 60 (3), 262-8
DOI 10.1097/FJC.0b013e31825de0bf, PubMed 22592773

Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC (2012)
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
Eur Heart J, 34 (12), 886-893c
DOI 10.1093/eurheartj/ehs262, PubMed 22942338

Publications 2002

Andersen IA, Hammerstrøm J (2002)
[Warfarin treatment of venous thromboembolism]
Tidsskr Nor Laegeforen, 122 (10), 1012-6
PubMed 12082693